DSLP

DSLP (Deep Science Limited Partnership) is the venture creation arm of Deep Science Ventures (DSV), a London-based venture builder that focuses on creating high-impact science companies from scratch. The company operates by identifying fundamental constraints in specific sectors, including curative oncology, neurodegeneration, and synthetic biology, and then recruiting specialized founders to build companies that address these gaps. DSLP provides the initial infrastructure, intellectual property framework, and seed funding to transition these concepts into independent biotech entities. Its portfolio includes a diverse range of startups working on novel therapeutic modalities such as advanced cell therapies, targeted small molecules, and platform technologies for drug discovery. By integrating deep scientific expertise with a structured venture-building methodology, DSLP aims to accelerate the development of breakthrough healthcare solutions.